Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that Abbott India NSI:ABB...
ABBOTINDIA — Abbott India Share Price
0.000.00%
Last Trade - 00:00HealthcareBalancedLarge CapHigh Flyer
- IN₹404.70bn
- IN₹381.61bn
- IN₹44.64bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 47.19 | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | 0.9% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Mar | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 29,386.91 | 33,071.22 | 36,786.03 | 40,931.44 | 43,100.2 | 48,712.2 | 54,504.77 | 10.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +8.36 | +34.46 | +19.34 | +33.59 | +16.44 | +18.43 | +12.65 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for ABBOTINDIA
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...
If, as an investor, you’re only looking at sales and earnings growth, there's a chance that a vital question is not being asked: how is that growth being funded? Top analysts and investors such as Warren Buffett and Michael Mauboussin...
Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - and Abbott India (NSI:ABBOTINDIA) could be one of them. To understand why differe...
Shares in Abbott India are currently trading at 16319 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether Abbott India is well placed to wi...
Profile Summary
Abbott India Limited is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Its business operations are divided into four business divisions: Women's Health & Gastrointestine, Gastroenterology and Hepatic Care; Specialty Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestine, Gastroenterology and Hepatic Care division has a mix of global and local brands present in the pregnancy, constipation and liver diseases segments. The Specialty Care division consists of a range of products in the treatment of central nervous system and metabolic disorders. The GenNext division focuses on several therapy areas, including pain management, vitamins and pregnancy. Its vaccines include Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present in the over the counter antacid segment.
Directors
- Munir Ahmed Shaikh (73)
- Rajiv Sonalker CFO
- Krupa Anandpara
- Ambati Venu VPR
- Anil Joseph (45)
- Vishwanath Swarup
- Purnajit Gupta
- Rashmi Hegde
- Rumy Kanga
- Mahadeo Karnik
- Sandeep Khandelwal
- Ashok Nair
- Ramanathan V.
- Nagesh Voleti OTH
- Sabina Ewing
- Kaiyomarz Marfatia NED
- Sudarshan Jain IND
- Shalini Kamath
- Anisha Motwani (54)
- Rajendra Shah NID (89)
- Last Annual
- March 31st, 2021
- Last Interim
- June 30th, 2021
- Incorporated
- August 22nd, 1944
- Public Since
- November 3rd, 1994
- No. of Shareholders
- 87,794
- No. of Employees
- 3,585
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 21,249,302
- Address
- 3-4 Corporate Park, MUMBAI, 400051
- Web
- http://www.abbott.co.in/
- Phone
- +91 2238162000
- Contact
- Krupa Anandpara
- Auditors
- S R B C & CO LLP
Latest News for ABBOTINDIA
Upcoming events for ABBOTINDIA
Q2 2022 Abbott India Ltd Earnings Release
Similar to ABBOTINDIA
AAREY DRUGS & PHARMACEUTICALS ORD
National Stock Exchange of India
AARTI DRUGS ORD
National Stock Exchange of India
ALEMBIC ORD
National Stock Exchange of India
ALEMBIC PHARMACEUTICALS ORD
National Stock Exchange of India
ALKEM LABORATORIES ORD
National Stock Exchange of India
FAQ
What is the Abbott India share price?
As of Today at 19:54 UTC, shares in Abbott India are trading at IN₹19,045.30. This share price information is delayed by 15 minutes.
How has the Abbott India share price performed this year?
Shares in Abbott India last closed at IN₹19,045.30 and the price had moved by +15.18% over the past 365 days. In terms of relative price strength the Abbott India share price has underperformed the S&P BSE 100 Index by -21.82% over the past year.
What are the analyst and broker recommendations for Abbott India?
The overall consensus recommendation for Abbott India is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Abbott India dividend yield?
The Abbott India dividend yield is 0.63% based on the trailing twelve month period.
Does Abbott India pay a dividend?
Last year, Abbott India paid a total dividend of IN₹120.00, and it currently has a trailing dividend yield of 0.63%. We do not have any data on when Abbott India is to next pay dividends.
When does Abbott India next pay dividends?
We do not have data on when Abbott India is to next pay dividends. The historic dividend yield on Abbott India shares is currently 0.63%.
How do I buy Abbott India shares?
To buy shares in Abbott India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Abbott India?
As of the previous close price of IN₹19,045.30, shares in Abbott India had a market capitalisation of IN₹404.70bn.
Where are Abbott India shares listed?
Here are the trading details for Abbott India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ABBOTINDIA
What kind of share is Abbott India?
Based on an overall assessment of its quality, value and momentum Abbott India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Abbott India share price forecast for 2021?
The analyst consensus target price for shares in Abbott India is IN₹18,649.50. That is 2.08% below the last closing price of IN₹19,045.30.
Analysts covering Abbott India currently have a consensus Earnings Per Share (EPS) forecast of IN₹385.03 for the next financial year.
What is the trend in the Abbott India share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abbott India. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +16.51%.
As of the last closing price of IN₹19,045.30, shares in Abbott India were trading +20.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Abbott India PE Ratio?
The Abbott India PE ratio based on its reported earnings over the past 12 months is 54.74. The shares last closed at IN₹19,045.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Abbott India?
Abbott India's management team is headed by:
- Munir Ahmed Shaikh -
- Rajiv Sonalker - CFO
- Krupa Anandpara -
- Ambati Venu - VPR
- Anil Joseph -
- Vishwanath Swarup -
- Purnajit Gupta -
- Rashmi Hegde -
- Rumy Kanga -
- Mahadeo Karnik -
- Sandeep Khandelwal -
- Ashok Nair -
- Ramanathan V. -
- Nagesh Voleti - OTH
- Sabina Ewing -
- Kaiyomarz Marfatia - NED
- Sudarshan Jain - IND
- Shalini Kamath -
- Anisha Motwani -
- Rajendra Shah - NID
Who are the major shareholders of Abbott India?
We do not have data on Abbott India's shareholders